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Abstract
Background: Pilocytic Astrocytoma (PA) is a common type of brain tumor in the
pediatric population. They have a fairly good prognosis. This study describes PAs in
detail, with a focus on the demographic factors, presenting features, management
and prognosis, and aims, to identify the negative outcome predictors in our
population, which can affect the course of the disease. This article will add to the
understanding of PAs from a third world perspective.
Methods: The Aga Khan University medical records (1995 – 2007) were reviewed,
to study the clinical features, management, and outcome of patients (0 – 15 years)
with Pilocytic Astrocytomas (PAs) in our population. After a thorough review of
the medical records, all the PAs diagnosed on the basis of histopathology at our
Pathology Laboratory, during this period, were included in the study.
Results: Twenty-two patients were included with a mean age of 9.25 years.
Male-to-female ratio was 1 : 1. The most common presenting feature was a sign
of increased intracranial pressure. The most common location was the cerebellum
followed by the cerebrum. Fifteen patients underwent maximum surgical resection.
Three had recurrence, despite no residual tumor. There were 10 Intensive Care
Unit (ICU) admissions and one inpatient mortality. Fifteen patients followed up in
the clinic: Eight had recurrence and four underwent repeat surgery (three showed
clinical improvement). Hydrocephalus was a predictor of ICU admission. Solid
consistency was found to be a marker of recurrence.
Conclusion: Pilocytic Astrocytomas are the most common pediatric brain tumors in
our population, commonly located in the cerebellum. Complete resection is the best
treatment option, but some tumors are aggressive and recurrence is not uncommon.
The possible negative outcome predictors are age, source of admission, extent of
resection, hydrocephalus, and solid consistency.
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INTRODUCTION
Pilocytic Astrocytoma (PA) is a common type of brain
tumor in the pediatric population. PAs comprise of 19.1%
of all pediatric brain tumors in the age group 0 – 14
years,[1] and have been reported to be the most common
gliomas and cerebellar tumors in children.[6,8] They can
involve the entire neuroaxis, but the cerebellum is the
most common site of origin. Due to lack of populationbased studies, the actual incidence is not clear, but
Burkhard et al.[7] reported an incidence of 4.8 per one
million in the Canton of Zurich, Switzerland, while
the Central Brain Tumor Registry of the United States
(CBTRUS) reports it to be 2.9 per million in the US.[1]
PAs are associated with a relatively benign clinical course.
They have a fairly good prognosis with a five-year survival
rate of 80 – 90%[12] and a 10-year survival rate of 81%,[13]
depending on the tumor location and extent of resection.
This may reflect the tumor’s slow growth and discrete
nature, which allow complete surgical resection.[11]
However, some of these tumors are more aggressive, have
a higher rate of recurrence, and a poor prognosis. It is
important to identify these patients correctly, as surgical
treatment is usually curative.[3] In this article, we present
our experience with PAs in the pediatric population.
This study describes PAs in detail, with a focus on the
demographic factors, presenting features, management
and prognosis, and aims, to identify the negative outcome
predictors in our population, which can affect the course
of the disease. This article will add to the understanding
of PAs from a third world perspective.

MATERIALS AND METHODS
This was a retrospective cross-sectional study. The Aga
Khan University Hospital (AKUH) medical records
were reviewed for a twelve-year period (1995 – 2007),
after approval from the Ethical Review Committee of
the AKUH, to identify pediatric brain tumor patients.
The pediatric population was defined as patients aged
below 15 years at the time of admission in our hospital.
The patients were referred to our institution by various
physicians in the community. As AKUH is one of the few
centers in Pakistan operating on pediatric brain tumors,
our referral catchment area was countrywide. After a
thorough review of the medical records, all PAs diagnosed
on the basis of histopathology at our Pathology Laboratory,
during this period, were included in the study. Data was
collected using a proforma on the following variables:
age, gender, source of admission (Emergency Room or
Consulting Clinic), presenting symptoms, radiological
findings, tumor location, surgical management, adjuvant
therapy (radiotherapy and chemotherapy), ICU
admission, Inpatient mortality, neurological condition on
discharge, duration of follow-up, neurological condition
on follow-up in the clinic, recurrence, repeat surgery for
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recurrence, and late mortality. The association between
the patient characteristics of age, gender, source of
admission, hydrocephalus, and consistency, with the
outcomes of ICU admission, recurrence, and repeat
surgery were tested using Fisher’s exact tests. On account
of the small sample sizes, multivariate modeling was
not possible. P-values less than 0.05 were considered
significant. All analyses were done using the SAS version
9.2.

RESULTS
During the 12-year period of 1995 – 2007, 102 pediatric
brain tumors were operated and 22 (21.6%) patients
were diagnosed with Pilocytic Astrocytoma, based on the
histopathology.

Demographics

The mean age of the patients was 9.25 years, with most
of the patients presenting in the adolescent age group of
10 to 15 years [Figure 1a]. Gender distribution was equal,
with a male-to-female ratio of 1 : 1, but there was a male
preponderance in the higher age group [Figure 1c]. Out
of 22 patients, 18 (81.8%) were admitted from consulting
clinics, while four (18.2%) were admitted through the
Emergency Room. The duration of stay in the hospital
ranged from two days to 46 days, with an average stay
in the hospital of 12.4 days. The duration of stay in the
hospital was longer in the younger age group [Figure 1d].

Presenting clinical and radiological features

Most of the patients (81.8%) presented with a Glasgow
Coma Scale (GCS) of 15 / 15. Only one patient had
a GCS of 3 and one had a GCS of 7. All the patients
presented with more than one clinical sign, with signs of
increased intracranial pressure (86.4%) being the most
common, followed by focal neurological signs (52.9%)
[Table 1].
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Figure 1:Variation of (a) Distribution, (b) Location, (c) Gender, and
(d) Duration of stay, with age
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A majority of our patients were diagnosed radiologically
on the basis of magnetic resonance imaging (MRI).
The MRI was used as a single diagnostic modality in
12 (54.5%) patients, while computed tomography (CT)
was used in three (13.6%) patients, but seven (31.8%)
patients underwent both CT and MRI. Hydrocephalus
was seen in nine (40.9%) cases. A cystic component was
present in nine (40.9%) cases, while the remaining 13
(59.1%) were of solid consistency. A total of six (27.3%)
cases showed contrast enhancement.

Location of tumors

Pilocytic Astrocytomas showed a predilection for the
cerebellum; 11 (50%) were found in the cerebellum, eight
(36.4%) in the cerebrum, two (9.1%) in brainstem, and
one (4.5%) in the basal ganglia [Figure 2]. The location
of the tumor also varied with age; the cerebrum was the
most common location in the 5 – 10 year age group, while
the cerebellum was the most common location in the
10 – 15 year age group [Figure 1b]. Among all pediatric
brain tumors (n = 102), PAs were found to be the most
common cerebral tumors (19.5%) and the second most
common cerebellar tumors (33.3%), the most common
being medulloblastoma (36.4%).

Histological features

Table 2 shows the histopathological details of all the
tumors. Rosenthal fibers were present in 15 (68.2%)
cases and microcysts were identified in 12 (54.5%), which
were also associated with eosinophilic bodies. Fibrillary
background was found in 17 (77.3%) of the tumors, but
five (22.7%) were found to have a myxoid background.
Other features were apparent only in a few cases: necrosis
in three (13.6%), vascularity in five (22.7%), and mitoses
in three (13.6%) of the cases.

Management

Surgical resection remained the mainstay of treatment,
as all our patients underwent craniotomy, mostly for
resection, with only two undergoing a biopsy. Out of
these two patients, one died during the hospital stay and
the other one did not show any clinical improvement
(CI) on discharge.
Complete resection was attempted in 15 (68.2%) patients.
Postoperative imaging was done in 10 of these patients;
there was no residual tumor seen in seven of them, but
three of the patients had a residual tumor. Even after no
evidence of residual tumor in postoperative imaging, three
patients had recurrence; one was given radiotherapy after
repeat surgery, while one was treated with chemotherapy
without any repeat surgery. The former showed clinical
improvement, but the latter did not. Of the five (22.7%)
patients who underwent partial resection, one was
treated with postoperative radiotherapy, and one had late
mortality, after 8.4 years, during the initial postoperative
course of repeat craniotomy, due to recurrence of tumor.
An extraventricular drain (EVD) was placed in seven
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Table 1: Presenting complaints of the patients
Presenting symptoms

n = 22

Focal Neurological Signs
Motor Deficit in Limbs
Cranial Nerve Deficit
Seizures
Balance Difficulty
Symptoms of Raised ICP
Headache
Nausea
Vomiting
Drowsiness

7
4
5
5
19
17
3
14
3

Brainstem
9%

Basal
Ganglia
5%

Cerebellum
50%
Cerebrum
36%

Figure 2: Location of pilocytic astrocytomas

Table 2: Different histological features of pilocytic
astrocytomas
Histological features

%

Fibrillary Background
Rosenthal Fibers
Microcysts
Eosinophilic Bodies
Cellular Pleomorphism
Vascularity
Myxoid Background
Calcification
Necrosis
Mitoses

77.8
66.7
55.6
55.6
27.8
22.2
22.2
11.1
11.1
11.1

patients before craniotomy, with two of them needing
a ventriculoperitoneal shunt (VPS) later on. VPS alone
was placed in three patients. Figure 3 shows how the
extent of resection of the tumor affected the subsequent
management and outcome of the patients.

Outcome

Ten (45%) patients were admitted in the Intensive
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Figure 3: Treatment pathway of 22 surgically operated Pilocytic Astrocytomas: Extent of resection, subsequent management, and outcome.
CI: Clinical improvement, FUP: Follow-up

Care Unit (ICU) and one (4.5%) patient died during
the hospital course. This patient underwent biopsy of a
tumor in the cerebrum. Most of the patients, 20 (90.9%),
had neurological improvement on discharge. Out of
22, 15 (68.2%) patients came for follow-up visits in the
clinic and 11 (73.3%) showed progressive neurological
improvement. The follow-up time period ranged from
three months to 12 years, with a mean follow-up period
of 3.72 years [Figure 4]. Recurrence was observed in eight
(53.3%) of these patients, of whom four underwent repeat
surgery. The time of recurrence ranged from eight months
to 8.4 years and the mean time period for recurrence was
found to be 3.7 years. Patients who did not have repeat
surgery showed no clinical improvement, while three of
the four patients who underwent repeat surgery showed

clinical improvement, and one patient died after repeat
surgery due to status epilepticus.

Predictors of negative outcome

A number of factors (e.g., age, source of admission,
gender, location of tumor, cystic component, contrast
enhancement, hydrocephalus, and extent of resection)
were considered, which could affect the postoperative
course, functional status, and prognosis of the patients
[Table 3]. Inpatient mortality and late mortality, were
both seen in the age group of 1 – < 5 years, although
recurrence was more common in the older age groups. Out
of the 10 ICU admissions, three (33%) were females (P =
017). Tumor recurrence was higher in males (P = 0.019).
Admission through the Emergency Room (ER) led to
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Figure 4: Follow-up of 15 patients ranging from 0 – 12 years. CI: Clinical improvement, FUP: Follow-up

Table 3: Predictors of negative outcome (age, source of admission, solid consistency, and hydrocephalus) in patients
with ICU admission, Inpatient mortality, recurrence, and late mortality
Age

ICU Admission
Inpatient Mortality
Recurrence
Repeat Surgery
Late Mortality

Gender

1- < 5

5- < 10

10 – 15

Male

Female

1
25%
1
100%
1
12.5%
1
20%
1
100%

1
25%
0
0%
4
50%
3
60%
0
0%

2
50%
0
0%
3
37.5%
1
20%
0
0%

1
25%
0
0%
4
50%
2
40%
1
100%

3
75%
1
100%
4
50%
3
60%
0
0%

three (30%) ICU admissions, but did not affect the longterm clinical outcome. Hydrocephalus was found to be a
negative outcome predictor in terms of ICU admission,
repeat surgery, and late mortality [Tables 3 and 4].
The extent of resection was also a negative outcome

Source of
Admission
ER
CC
3
75%
1
100%
1
12.5%
0
0%
0
0%

1
25%
0
0%
7
87.5%
5
100%
1
0%

Hydrocephalus

Consistency

Yes

No

Solid

Cystic

1
25%
0
0%
5
62.5%
4
80%
1
100%

3
75%
1
100%
3
37.5%
1
20%
0
0%

1
25%
0
0%
3
37.5%
2
40%
1
100%

3
75%
1
100%
5
62.5%
3
60%
0
0%

predictor in terms of Inpatient mortality and late
mortality [Figure 3]. The solid consistency of tumors led
to a poor prognosis, as it was associated with a greater
number of ICU admissions, recurrence of tumors, and
repeat surgeries (60%) [Tables 3 and 4].
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Table 4: Associations of demographic and clinical characteristics with outcomes of interest
Variable

Response

Overall

N

# with ICU
admission
(%)

19

10 (53)

P-value

# with
Recurrence
(%)

P-value

8 (42)

# with Repeat
surgery
(%)

P-value

4 (21)

Age

<5
5- < 10
10 – 15

5
6
8

3 (60)
3 (50)
4 (50)

> 0.99

1 (20)
2 (33)
5 (63)

0.435

1 (20)
0 (0)
3 (38)

0.309

Gender

Male
Female

10
9

7 (70)
3 (33)

0.178

7 (70)
1 (11)

0.019

4 (40)
0 (0)

0.086

Source of Admission

ER
Clinic

5
14

3 (60)
7 (50)

> 0.99

4 (80)
4 (29)

0.110

2 (40)
2 (14)

0.272

Hydrocephalus

Yes
No
Solid
Cystic

11
8
6
13

10 (91)
0 (0)
4 (67)
6 (46)

< 0.001

7 (64)
1 (13)
6 (100)
2 (15)

0.058

4 (36)
0 (0)
2 (33)
2 (15)

0.103

Consistency

DISCUSSION
Pilocytic Astrocytomas were found to be the most
common pediatric brain tumors (21.6%) in our study
population, which was comparable to the CBTRUS,[1]
which showed that the incidence of PAs was 19.1% in
the 0 – 14 years age group, and Rickert and Paulus,[19]
who observed that PAs comprised of 23.5% of their
study population. However, some studies showed that
prevalence could be as low as 5.5%, [7] although there
was no evidence of increased incidence of PA in any
racial or ethnic group.[18] The male-to-female ratio in
our population was 1 : 1, which was comparable to 1.12
according to Burkhard et al.[7] and the general trend of
no gender predilection observed in PAs.[6] The mean age
of 9.25 years observed in our study was similar to the
mean age of 8 years noted by Krieger et al.[15] and 10.6
years observed in a study by Malik et al.[16] Although PA
was a slow growing tumor, four (18.4%) of the patients
were admitted through ER. This was unusual and it had
a significant impact on the prognosis of the patient.
The most common presenting complaints were signs of
increased intracranial pressure (ICP) (86.4%) and focal
neurological deficits (50%), which were comparable to
other studies.[2,3,9]
Pilocytic Astrocytomas could arise in various locations
in the neuroaxis, such as, the optic nerve, optic chiasm,
hypothalamus, cerebellum, brain stem, thalamus,
basal ganglia, and cerebral hemispheres. In our study,
they showed a predilection toward the posterior fossa,
particularly the cerebellum (50%). Aarsen et al.[2] and
Fernandez et al.[9] reported a similar trend, but their

0.628

0.001

0.557

cases were also located in the optic chiasm and spinal
cord. The MRI and CT scan showed a cystic component
in 40.9% of the patients and contrast enhancement in
20.3%. PAs appearing solid on the MRI were presumed
to be more aggressive. Our study also showed differences
in the outcome of solid and cystic PAs, but these were
not statistically significant. Strong et al.[21] evaluated
the radiological images of PAs with regard to tumor
distribution, size, morphological appearance, calcification,
and degree of contrast enhancement, in their study, but
we were unable to distinguish tumors that would follow
an aggressive course from the tumors that would behave
in a more benign manner. Thus, they concluded that
imaging features were unreliable in predicting clinical
behavior. Maximum resection was attempted in 15
patients; seven (46.7%) of them had no residual tumor,
five (33.3%) had residual tumor, and three (20%) did
not have any postoperative imaging. Studies showed
that direct neurosurgical evaluation of the extent of
resection was surprisingly unreliable, and postoperative,
contrast-enhanced, cross-sectional imaging, preferably
MRI, was essential for definitive assessment.[14,20,22]
Complete resection led to a better outcome, with most
of the patients showing clinical improvement, and there
was no Inpatient or late mortality. This showed the
curative potential of resection, with no identifiable tumor
left behind, as shown by other studies.[7,9] However,
three (42.9%) of the seven patients in our study showed
recurrence, even though there was no evidence of a
postoperative residual tumor on imaging. This could be
correlated with the findings of Strong et al.,[21] which
stated more than one-third of their patients with PAs
followed an unusually aggressive course, with progression,
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or a recurrent tumor identified despite concurrent
treatment.
There exists a subset of patients who have an aggressive
clinical course and require multiple resections or other
therapies to control tumor growth.[22] The reason for
the aggressive behavior of the PAs, compared with most
other studies describing PA as a benign entity, is unclear.
Patients with only a tumor biopsy done, did not show any
clinical improvement and one had Inpatient mortality.
Partial resection led to recurrence in two (40%) patients
and late mortality in one (20%) patient. Adjuvant
therapy in the form of chemo- and radiotherapy was not
necessary in PAs that were completely resected.[9] Very
few patients with recurrence or partially resected tumors
underwent chemotherapy and radiotherapy in our study
and did not show clinical improvement if not combined
with repeat resection.. Impact on survival by these
adjuvant modalities is still controversial[7] and careful
patient selection must be done.
Out of the total, 15 patients came for follow-up in
clinics. Only one late mortality was seen after 8.4
years, although eight patients had recurrence, and four
underwent repeat surgery. Those patients who underwent
repeat surgery showed clinical improvement, while
others did not. It was found in a study conducted, in
2001, that repeat surgery for tumors located in the
cerebral hemispheres or cerebellum resulted in gross total
resection or near total resection in all cases and resulted
in long periods of progression-free survival, without
further adjuvant treatment.[5] The time of recurrence
ranged from eight months to 8.4 years and the mean
time period for recurrence was found to be 3.7 years,
which was comparable to another study, which showed
that recurrence occurs between one and eight years.[3]
Due to variations in the prognosis of all the patients, we
tried to find out the predictors of negative outcomes.
Previous studies have identified several risk factors for
tumor recurrence / progression including, age, site, and
extent of resection, although several of these remain
controversial.[4,10,17]
Aarsen et al.[2] found that disabilities were more
significant in the supratentorial as compared to the
infratentorial PAs. Berger et al.[4] noted that the extent
of resection was significantly related to the recurrence
of tumor. A retrospective study of 80 cases of PAs
concluded that some clinicopathological factors, such as,
partial resection, optochiasmatic location, invasion of the
surrounding structures, and the pilomyxoid variant, had
a worse prognosis.[9] In our study population, age, gender,
source of admission, hydrocephalus, solid consistency,
and the extent of resection, were found to be poor
prognostic factors, whereas, location of the tumor and
contrast enhancement on imaging did not have any effect
on the prognosis. Although these factors were suggestive
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of poor outcome, the statistical significance could not
be determined, due to the small sample size. Therefore,
further population-based studies should be conducted to
validate the identified predictors of negative outcomes.

CONCLUSION
Pilocytic Astrocytomas are the most common pediatric
brain tumors in our population and are most commonly
located in the cerebellum. Complete surgical resection
is the best treatment option for PAs. However, some
tumors follow an aggressive course and recurrence is not
uncommon. A second surgical resection after recurrence
has a likelihood of better prognosis. The negative
outcome predictors, according to our study, are age,
source of admission, extent of resection, solid consistency,
and hydrocephalus. As the number of cases in our study
is small, there is a need to do a larger study, with more
cases of PAs in the Pakistani population, to determine
if there are any ethnic differences in the epidemiology,
prognostic factors, and outcomes, as compared to other
studies from different parts of the world.
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